Redhill Biopharma
RDHL
$0.45
Share price
0.11%
Change (1 day)
-79.05%
Change (1 year)
Categories
Market capitalization of Redhill Biopharma (RDHL)
Market cap: $14.35 Million
As of May 2024 Redhill Biopharma has a market cap of $14.35 Million. This makes Redhill Biopharma the world's 8070th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Redhill Biopharma from 2013 to 2024
End of year Market Cap
| Year | Market cap | Change |
|---|---|---|
| 2024 | $14.35 M | -50.02% |
| 2023 | $28.72 M | 124.48% |
| 2022 | $12.79 M | -90.54% |
| 2021 | $0.13 B | -55.61% |
| 2020 | $0.30 B | 42.27% |
| 2019 | $0.21 B | 35.97% |
| 2018 | $0.15 B | 43.99% |
| 2017 | $0.10 B | -38.72% |
| 2016 | $0.17 B | 8.98% |
| 2015 | $0.16 B | 39.76% |
| 2014 | $0.11 B | 54.16% |
| 2013 | $75.99 M |
End of Day market cap according to different sources
On May 2nd, 2024 the market cap of Redhill Biopharma was reported to be:
$14.35 Million
$14.35 Million
$14.35 Million
$0.39 Million
Market capitalization for similar companies or competitors
| Name | Market cap | Market cap differencediff. | Country |
|---|---|---|---|
 Sanofi SNY | $124.49 B | 867,102.07% | 🇫🇷 France |
 Merck MRK | $324.88 B | 2,262,957.23% | 🇺🇸 USA |
 GlaxoSmithKline GSK | $88.39 B | 615,604.69% | 🇬🇧 UK |
 Teva Pharmaceutical Industries TEVA | $15.94 B | 110,985.80% | 🇮🇱 Israel |
 Taro Pharmaceutical TARO | $1.59 B | 11,029.23% | 🇮🇱 Israel |